Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test September 19, 2025 Standard Uranium Executes Letter of Intent to Option Rocas Uranium Project in Eastern Athabasca Basin September 19, 2025 Dollar Doubts: Why Crypto Could Gain Ground as an Investor Safe Haven September 19, 2025
Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test September 19, 2025
Standard Uranium Executes Letter of Intent to Option Rocas Uranium Project in Eastern Athabasca Basin September 19, 2025